Insider filing · PROK

Control Empresarial de Capitales S.A. de C.V. bought $275K of ProKidney (PROK)

Executed Apr 22 2025, disclosed Apr 24 2025, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Apr 24 2025), the stock returned -19.9% (delay-adjusted); from the execution session (Apr 22 2025), +7.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

CV Control Empresarial de Capitales S.A. de C.V. 10% owner profile →

Control Empresarial de Capitales S.A. de C.V. (10% owner) filed 57 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 57 sales), most often in PBF Energy Inc. (PBF). The largest single filing was $106.8M of TALO (6,240,000 sh across 3 lots, as filed), executed Oct 8.

PROK ProKidney Corp. PROK · Healthcare · 6 filings in 24 months ticker →

Healthcare · ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney d…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→